secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001104659-25-047040
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium enters $25M accelerated share repurchase; 692,281 shares initially delivered
--------------------------------------------------------------------------------

- ASR with Jefferies for $25M; part of $150M repurchase program authorized Jan 2024.
- Initial delivery of 692,281 shares (approx 80% of expected) at $28.89 closing price on May 9.
- Final settlement expected by Q3 2025; shares based on volume-weighted average price.
- As of March 31, 2025, Collegium had ~32.1M shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925047040/0001104659-25-047040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465925047040/tm2514636d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-047040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer